Enhanced targeting efficiency of PLGA microspheres loaded with Lornoxicam for intra-articular administration

Drug Delivery

Volumn 18, Issue 7, 2011, Pages 536-544

  Zhang, Zhiyue ^a   Bi, Xiuli ^a   Li, Hui ^b   Huang, Guihua ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

intra articular administration; Lornoxicam; microsphere; PLGA; targeting delivery

Indexed keywords

LORNOXICAM; MICROSPHERE; POLYGLACTIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DIFFERENTIAL SCANNING MICROSCOPY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG RETENTION; DRUG SYNOVIAL FLUID LEVEL; ENCAPSULATION; IN VITRO STUDY; MAXIMUM PLASMA CONCENTRATION; MICROSCOPY; NONHUMAN; PARTICLE SIZE; PHYSICOCHEMICAL MODEL; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; RABBIT; RAT; SCANNING ELECTRON MICROSCOPY; SYNOVIAL FLUID; TIME TO MAXIMUM PLASMA CONCENTRATION; ZETA POTENTIAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EMULSIONS; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; PIROXICAM; POLYGLYCOLIC ACID; RABBITS; RATS; RATS, WISTAR; SYNOVIAL FLUID; TISSUE DISTRIBUTION;

EID: 80052935320     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2011.596584     Document Type: Article

References (37)

1. A., Kishida JBD, S., Yoshioka, Y., Aso, Y., Takeda (1990). Some Determinants of Morphology and Release Rate from Poly(L) Lactic Acid Microspheres Journal of Controlled Release.13, 83-89. (Pubitemid 20221204)
2. Ayan E, Kaplan MB, Koksela O, Tamer L, Karabacak T, Ayaz LOzdulger A (2008). Efficiency of Lornoxicam in Lung and Trachea Injury Caused by Peroxynitrite. Pulmonary Pharmacology and Therapeutics.21, 201-207.
3. Berg J, Fellier H, Christoph T, Grarup JStimmeder D (1999). The Analgesic Nsaid Lornoxicam Inhibits Cyclooxygenase (Cox)-1/-2, Inducible Nitric Oxide Synthase (Inos), and the Formation of Interleukin (Il)-6 in Vitro. Inflammation Research.48, 369-379.
4. Betre H, Liu W, Zalutsky MR, Chilkoti A, Kraus VBSetton LA (2006). A Thermally Responsive Biopolymer for Intra-Articular Drug Delivery. J Control Release.115, 175-182. (Pubitemid 44537500)
5. Bigi A, Cojazzi G, Panzavolta S, Rubini KRoveri N (2001). Mechanical and Thermal Properties of Gelatin Films at Different Degrees of Glutaraldehyde Crosslinking. Biomaterials.22, 763-768. (Pubitemid 32146149)
6. Ding Yue DH, Shangli Liu, Ruofan Ma (2004). The Efficacy and Safety of Lornoxicam in Treatment of Rheumatoid Arthritis and Osteoarthritis. Chinese journal of new drugs.13, 562-564.
7. Draye JP, Delaey B, Van de Voorde A, Van Den Bulcke A, De Reu BSchacht E (1998). In Vitro and in Vivo Biocompatibility of Dextran Dialdehyde Cross-Linked Gelatin Hydrogel Films. Biomaterials.19, 1677-1687. (Pubitemid 28512848)
8. Freitas S, Merkle HPGander B (2005). Microencapsulation by Solvent Extraction/Evaporation: Reviewing the State of the Art of Microsphere Preparation Process Technology. J Control Release.102, 313-332. (Pubitemid 40093756)
9. Gerwin N, Hops CLucke A (2006). Intraarticular Drug Delivery in Osteoarthritis. Adv Drug Deliv Rev.58, 226-242.
10. Gerwin N, Hops CLucke A (2006). Intraarticular Drug Delivery in Osteoarthritis. Advanced Drug Delivery Reviews.58, 226-242.
11. Guo L, Liu G, Hong RYLi HZ (2010). Preparation and Characterization of Chitosan Poly(Acrylic Acid) Magnetic Microspheres. Mar Drugs.8, 2212-2222.
12. H S (1997). Microencapsulation Techniques Using Ethyl Acetate as a Dispersed Solvent: Effects of Its Extraction Rate on the Characteristics of Plga Microspheres. Journal of Controlled Release.47, 233-245.
13. Horisawa E, Hirota T, Kawazoe S, Yamada J, Yamamoto H, Takeuchi HKawashima Y (2002). Prolonged Anti-Inflammatory Action of Dl-Lactide/Glycolide Copolymer Nanospheres Containing Betamethasone Sodium Phosphate for an Intra-Articular Delivery System in Antigen-Induced Arthritic Rabbit. Pharm Res.19, 403-410. (Pubitemid 34408936)
14. Hunter DJ, McDougall JJ, Keefe FJ (2008). The Symptoms of Osteoarthritis and the Genesis of Pain. Rheumatic Diseases Clinics of North America.34, 623-643.
15. Inoue A, Takahashi KA, Arai Y, Tonomura H, Sakao K, Saito M, Fujioka M, Fujiwara H, Tabata YKubo T (2006). The Therapeutic Effects of Basic Fibroblast Growth Factor Contained in Gelatin Hydrogel Microspheres on Experimental Osteoarthritis in the Rabbit Knee. Arthritis and Rheumatism.54, 264-270. (Pubitemid 43122211)
16. Liang LS, Jackson J, Min W, Risovic V, Wasan KMBurt HM (2004). Methotrexate Loaded Poly(L-Lactic Acid) Microspheres for Intra-Articular Delivery of Methotrexate to the Joint. J Pharm Sci.93, 943-956. (Pubitemid 38420405)
17. Liang LS, Wong WBurt HM (2005). Pharmacokinetic Study of Methotrexate Following Intra-Articular Injection of Methotrexate Loaded Poly(L-Lactic Acid) Microspheres in Rabbits. J Pharm Sci.94, 1204-1215. (Pubitemid 40904185)
18. M., Fransen SM, G., Hernandez-Molina, S., Reichenbach (2010). Does Land-Based Exercise Reduce Pain and Disability Associated with Hip Osteoarthritis? A Meta-Analysis of Randomized Controlled Trials. Osteoarthritis and Cartilage.18, 613-620.
19. McGinity JWO,Donnell PB (1997). Preparation of Microspheres by the Solvent Evaporation Technique. Adv Drug Deliv Rev.28, 25-42. (Pubitemid 27497672)
20. Morita T, Sakamura Y, Horikiri Y, Suzuki TYoshino H (2000). Protein Encapsulation into Biodegradable Microspheres by a Novel S/O/W Emulsion Method Using Poly(Ethylene Glycol) as a Protein Micronization Adjuvant. Journal of Controlled Release.69, 435-444.
21. Patil KR, Rane VP, Sangshetti JNShinde DB (2009). Stability-Indicating Lc Method for Analysis of Lornoxicam in the Dosage Form. Chromatographia.69, 1001-1005.
22. Patil S, Babbar A, Mathur R, Mishra ASawant K (2010). Mucoadhesive Chitosan Microspheres of Carvedilol for Nasal Administration. J Drug Target.18, 321-331.
23. Paulo Costa JMSL (2001). Modeling and Comparison of Dissolution Profiles. European Journal of Pharmaceutical Sciences.13 123-133.
24. Pruss TP, Stroissnig H, Radhofer-Welte S, Wendtlandt W, Mehdi N, Takacs FFellier H (1990). Overview of the Pharmacological Properties, Pharmacokinetics and Animal Safety Assessment of Lornoxicam. Postgraduate Medical Journal.66 Suppl 4, S18-21 (Pubitemid 20364810)
25. Reva C. Lawrence1, Charles, G. Helmick2, Frank, C. Arnett3, (1998). Estimates of the Prevalence of Arthritis and Selected Musculoskeletal Disorders in the United States. Arthritis & Rheumatism.41, 778-799.
26. Sakakibara Y, Nishimura K, Tambara K, Yamamoto M, Lu F, Tabata YKomeda M (2002). Prevascularization with Gelatin Microspheres Containing Basic Fibroblast Growth Factor Enhances the Benefits of Cardiomyocyte Transplantation. Journal of Thoracic and Cardiovascular Surgery.124, 50-56.
27. Saricaoglu F, Dal D, Atilla P, Iskit AB, Tarhan O, Asan EAypar U (2008). Effect of Intraarticular Injection of Lornoxicam on the Articular Cartilage & Synovium in Rat. Indian Journal of Medical Research.127, 362-365.
28. Sayre EC, Li LC, Kopec JA, Esdaile JM, Bar SCibere J (2010). The Effect of Disease Site (Knee, Hip, Hand, Foot, Lower Back or Neck) on Employment Reduction Due to Osteoarthritis. Plos One.5,.
29. Sen S, Doger FK, Aydin ON, Karul ADost T (2006). The Protective Effect of Nitroglycerin on Gastrointestinal and Renal Side Effects of Lornoxicam in Rats. Eur J Pharmacol.541, 191-197. (Pubitemid 43903487)
30. Shive MSAnderson JM (1997). Biodegradation and Biocompatibility of Pla and Plga Microspheres. Adv Drug Deliv Rev.28, 5-24. (Pubitemid 27497671)
31. Surh J, Decker EAMcClements DJ (2006). Properties and Stability of Oil-in-Water Emulsions Stabilized by Fish Gelatin. Food Hydrocolloids.20, 596-606. (Pubitemid 43261608)
32. Tabata Y, Hijikata S, Muniruzzaman MIkada Y (1999). Neovascularization Effect of Biodegradable Gelatin Microspheres Incorporating Basic Fibroblast Growth Factor. J Biomater Sci Polym Ed.10, 79-94. (Pubitemid 29097233)
33. Tabata YIkada Y (1989). Synthesis of Gelatin Microspheres Containing Interferon. Pharm Res.6, 422-427. (Pubitemid 19176088)
34. Tamber H, Johansen P, Merkle HPGander B (2005). Formulation Aspects of Biodegradable Polymeric Microspheres for Antigen Delivery. Adv Drug Deliv Rev.57, 357-376. (Pubitemid 39555502)
35. Tsung MJ, Burgess DJ (2001). Preparation and Characterization of Gelatin Surface Modified Plga Microspheres. AAPS PharmSci.3, 14-24.
36. Tuncay M, Calis S, Kas HS, Ercan MT, Peksoy IHincal AA (2000). In Vitro and in Vivo Evaluation of Diclofenac Sodium Loaded Albumin Microspheres. J Microencapsul.17, 145-155. (Pubitemid 30135792)
37. Zhang hu Zx, Li huifan 2006 The Effects of Lornoxicam on Chronic Arthritis in Rat. yunnan medicine.27, 420-422.